atenolol has been researched along with urea in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ax, F; Bonham, NM; Hallberg, A; Karlén, A; Lennernäs, H; Winiwarter, S | 1 |
| Danelian, E; Hämäläinen, MD; Hansson, A; Karlén, A; Karlsson, R; Lennernäs, H; Löfâs, S; Winiwarter, S | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Avdeef, A; Tam, KY | 1 |
| Apperloo, AJ; de Jong, PE; de Zeeuw, D; Sluiter, HE | 1 |
| Burgess, J; Cooper, WD; Davidson, C; Fairhurst, G; Petrie, JC; Richardson, PJ; Robb, OJ; Trafford, J; Vandenburg, MJ; Webster, J | 1 |
| Barsuhn, CL; Borchardt, RT; Ho, NF; Knipp, GT | 1 |
| Furuichi, Y; Sakamoto, A | 1 |
| Carr, M; Damian, DJ; McNamee, R | 1 |
| Goto, M; Hirakawa, Y; Kamiya, N; Miyano, T; Ueda, H | 1 |
1 review(s) available for atenolol and urea
| Article | Year |
|---|---|
[Perioperative cardiovascular evaluation and management for noncardiac surgery].
Topics: Adrenergic beta-Antagonists; Anesthesia; Atenolol; Bisoprolol; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Intraoperative Complications; Metoprolol; Monitoring, Intraoperative; Morpholines; Myocardial Infarction; Myocardial Ischemia; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Urea | 2014 |
3 trial(s) available for atenolol and urea
| Article | Year |
|---|---|
Differential effects of enalapril and atenolol on proteinuria and renal haemodynamics in non-diabetic renal disease.
Topics: Adult; Atenolol; Blood Pressure; Double-Blind Method; Enalapril; Female; Hemodynamics; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Prospective Studies; Proteinuria; Renal Circulation; Sodium; Urea | 1991 |
Enalapril in moderate to severe hypertension: a comparison with atenolol.
Topics: Adolescent; Adult; Aged; Atenolol; Blood Pressure; Creatinine; Drug Evaluation; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Random Allocation; Urea | 1986 |
Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Age Factors; Aged; Amiloride; Antihypertensive Agents; Atenolol; Biomarkers; Blood Glucose; Body Weight; Cholesterol; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Intention to Treat Analysis; Linear Models; Male; Potassium; Single-Blind Method; Sodium; Sodium Chloride Symporter Inhibitors; Time Factors; Treatment Outcome; United Kingdom; Urea; Uric Acid | 2016 |
8 other study(ies) available for atenolol and urea
| Article | Year |
|---|---|
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
Topics: Humans; Intestinal Absorption; Jejunum; Models, Biological; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship | 1998 |
SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans.
Topics: Humans; Intestinal Absorption; Liposomes; Pharmaceutical Preparations; Pharmacokinetics; Predictive Value of Tests; Surface Plasmon Resonance | 2000 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size.
Topics: Atenolol; Biological Transport; Caco-2 Cells; Cell Membrane Permeability; Chelating Agents; Chemical Phenomena; Chemistry, Physical; Diffusion; Drug Interactions; Egtazic Acid; Formates; Humans; Lactic Acid; Mannitol; Methylamines; Palmitoylcarnitine; Solutions; Structure-Activity Relationship; Tight Junctions; Urea | 1997 |
New insight into transdermal drug delivery with supersaturated formulation based on co-amorphous system.
Topics: Administration, Cutaneous; Animals; Atenolol; Drug Delivery Systems; In Vitro Techniques; Male; Mice, Hairless; Permeability; Polyethylene Glycols; Skin; Urea | 2019 |